These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23472229)

  • 1. Misidentification of putative medullary thyroid cancer cell lines RO-H85-1 and RO-D81-1.
    Dadon T; Ball D; Nelkin BD
    J Clin Endocrinol Metab; 2013 Mar; 98(3):954-5. PubMed ID: 23472229
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid cancer cell line misidentification: an update.
    Schweppe RE
    J Clin Endocrinol Metab; 2013 Mar; 98(3):956-7. PubMed ID: 23472230
    [No Abstract]   [Full Text] [Related]  

  • 3. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.
    Schweppe RE; Klopper JP; Korch C; Pugazhenthi U; Benezra M; Knauf JA; Fagin JA; Marlow LA; Copland JA; Smallridge RC; Haugen BR
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4331-41. PubMed ID: 18713817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Thyroid cancer" cell line misidentification: a time for proactive change.
    Ringel MD
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4226-7. PubMed ID: 18987282
    [No Abstract]   [Full Text] [Related]  

  • 5. Expansion of microsatellite in the thyroid hormone receptor-alpha1 gene linked to increased receptor expression and less aggressive thyroid cancer.
    Onda M; Li D; Suzuki S; Nakamura I; Takenoshita S; Brogren CH; Stampanoni S; Rampino N
    Clin Cancer Res; 2002 Sep; 8(9):2870-4. PubMed ID: 12231529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis.
    Cavaco BM; Batista PF; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary and non-medullary thyroid cancer in a family.
    Ardern-Jones A; Harvey RJ; Wilson P; Sharma AK; Murday V; Harmer C; Houlston RS
    Acta Oncol; 2004; 43(7):680-1. PubMed ID: 15545189
    [No Abstract]   [Full Text] [Related]  

  • 8. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
    Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
    Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curbing rampant cross-contamination and misidentification of cell lines.
    Nardone RM
    Biotechniques; 2008 Sep; 45(3):221-7. PubMed ID: 18816888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphism analysis in the human phosphatase PTPrj gene using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
    Powell N; Dudley E; Morishita M; Bogdanova T; Tronko M; Thomas G
    Rapid Commun Mass Spectrom; 2004; 18(19):2249-54. PubMed ID: 15384144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medullary thyroid carcinoma: from molecular studies to clinical decision].
    Włoch J; Oczko-Wojciechowska M; Szpak-Ulczok S; Jarzab B
    Endokrynol Pol; 2005; 56(3):362-9. PubMed ID: 16350733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.
    Gursoy A; Erdogan MF; Erdogan G
    J Endocrinol Invest; 2006 Nov; 29(10):858-62. PubMed ID: 17185892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer.
    Liska J; Altanerova V; Galbavy S; Stvrtina S; Brtko J
    Endocr Regul; 2005 Sep; 39(3):73-83. PubMed ID: 16468229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma].
    Cañadas Garre M; López de la Torre Casares M; Becerra Massare P; López Nevot MÁ; Villar Del Moral J; Muñoz Pérez N; Vílchez Joya R; Montes Ramírez R; Llamas Elvira JM
    Endocrinol Nutr; 2011 Apr; 58(4):175-84. PubMed ID: 21441079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspective.
    Ball DW
    Thyroid; 2009 Jun; 19(6):547-50. PubMed ID: 19499986
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582.
    Lima J; Máximo V; Soares P; Williams D; Bogdanova T; Thomas GA; Sobrinho-Simões M
    Carcinogenesis; 2003 Jun; 24(6):1155. PubMed ID: 12807747
    [No Abstract]   [Full Text] [Related]  

  • 19. Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.
    Na KY; Kim RM; Song EM; Lee JH; Lee J; Soh EY
    J Surg Oncol; 2012 Jan; 105(1):10-4. PubMed ID: 21826673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms.
    Zeki K; Spambalg D; Sharifi N; Gonsky R; Fagin JA
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1317-21. PubMed ID: 7962323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.